Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect: 2023-2025

Historic Exchange Rate Effect for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Sep 2025 value amounting to -$26,000.

  • Ironwood Pharmaceuticals' Exchange Rate Effect changed negligibly% to -$26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$659,000, marking a year-over-year decrease of 539.81%. This contributed to the annual value of -$32,000 for FY2024, which is 39.62% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Exchange Rate Effect is -$26,000, which was up 95.98% from -$647,000 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Exchange Rate Effect ranged from a high of $24,000 in Q1 2024 and a low of -$647,000 during Q2 2025.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$26,000 (2025), whereas its average is -$95,250.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 142.00% in 2024, then plummeted by 1,168.63% in 2025.
  • Quarterly analysis of 3 years shows Ironwood Pharmaceuticals' Exchange Rate Effect stood at -$50,000 in 2023, then surged by 142.00% to $21,000 in 2024, then remained steady at -$26,000 in 2025.
  • Its last three reported values are -$26,000 in Q3 2025, -$647,000 for Q2 2025, and -$7,000 during Q1 2025.